The Food and Drug Administration (FDA) has approved Aucatzyl ® (obecabtagene autoleucel; obe-cel) for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in ...
Syncona's Chief Executive Officer Chris Hollowood said: "We are delighted for Autolus to receive FDA approval for its novel CAR T-cell therapy for the treatment of adult ALL. Adult ALL is a ...
A mum who claims her GP said her four year-old daughter was 'faking it' a week before she was diagnosed with blood cancer is urging parents to trust their instincts. Rebecca Herbert’s daughter Summer, ...